Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.41 |
| ▸ | KIF11 | P52732 | 5/20 | 0.40 |
| ▸ | ARG1 | P05089 | 1/20 | 0.40 |
| ▸ | ARG2 | P78540 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 3/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | BHMT | Q93088 | 2/20 | 0.39 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.38 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2032831 | 1.00 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL360210 | 1.00 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL360209 | 1.00 | SLC7A5 (0.45) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL28948326 | 0.80 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL13988062 | 0.80 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL6542263 | 0.80 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL13902860 | 0.80 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL6542267 | 0.80 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL160076 | 0.80 | SLC7A5 (0.42) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 | |
| SCHEMBL5490023 | 0.80 | SLC7A5 (0.42) | SLC7A5SLC1A3SLC1A2SLC1A1KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2069473-A2 | ANTIBIOTIC ANTIMICROBIAL AGENTS AND METHODS OF THEIR USE | The Ohio State University Research Foundation (US) | 2009-06-17 | — | — | EP | claimed |
| WO-2008091416-A2 | ANTIBIOTIC ANTIMICROBIAL AGENTS AND METHODS OF THEIR USE | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2008-07-31 | — | — | WO | claimed |
| EP-1915389-A2 | DIFFERENTIALLY PROTECTED ORTHOGONAL LANTHIONINE TECHNOLOGY | Oragenics, Inc. (US) | 2008-04-30 | — | — | EP | claimed |
| WO-2007022012-A2 | DIFFERENTIALLY PROTECTED ORTHOGONAL LANTHIONINE TECHNOLOGY | ORAGENICS, INC. (US) | 2007-02-22 | — | — | WO | claimed |
| US-20260116929-A1 | ANTI-GRAM-NEGATIVE BACTERIAL COMPOUND | MURATA MANUFACTURING CO (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12428452-B2 | Anti-gram-negative bacterial compound | MURATA MANUFACTURING CO., LTD. (JP) | 2025-09-30 | — | — | US | disclosed |
| CN-119932141-A | Method for producing nisin by co-immobilized and co-fermented bacteria enzymes | 河北工业大学 | 2025-05-06 | — | — | CN | disclosed |
| US-20250129328-A1 | AN ISOLATED S. SALIVARIUS STRAIN AND ITS USE AS AN ANTIMICROBIAL PRODUCING PROBIOTIC | MUNSTER TECHNOLOGICAL UNIVERSITY (IE) | 2025-04-24 | — | — | US | disclosed |
| US-11987788-B2 | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains | S-BIOMEDIC NV (BE) | 2024-05-21 | — | — | US | disclosed |
| EP-3912630-B1 | METHODS AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF THE SKIN MICROBIOME USING COMPLEX MIXTURES OF BACTERIAL STRAINS | S BIOMEDIC NV (BE) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023118232-A1 | AN ISOLATED S. SALIVARIUS STRAIN AND ITS USE AS AN ANTIMICROBIAL PRODUCING PROBIOTIC | MUNSTER TECHNOLOGICAL UNIVERSITY (IE) | 2023-06-29 | — | — | WO | disclosed |
| EP-4198044-A1 | AN ISOLATED S. SALIVARIUS STRAIN AND ITS USE AS AN ANTIMICROBIAL PRODUCING PROBIOTIC | Munster Technological University (IE) | 2023-06-21 | — | — | EP | disclosed |
| EP-0700998-A1 | Recombinant mersacidin and a method for production | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-03-13 | — | — | EP | disclosed |
| WO-1995030751-A1 | LANTHIONINE-CONTAINING ANTIMICROBIAL COMPOUND | CIBA-GEIGY AG (CH) | 1995-11-16 | — | — | WO | disclosed |
| EP-0633939-A1 | NISINS | BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL (GB) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993020213-A1 | NISINS | AGRICULTURE AND FOOD RESEARCH COUNCIL (GB) | 1993-10-14 | — | — | WO | disclosed |
| US-5231013-A | Staphylococcus biosynthesis | DR. KARL THOMAE GMBH (DE) | 1993-07-27 | — | — | US | disclosed |
| EP-0508371-A1 | Isolation and purification of lantibiotics | Dr. Karl Thomae GmbH (DE) | 1992-10-14 | — | — | EP | disclosed |
| EP-0342486-B1 | ANTIBIOTIC | Dr. Karl Thomae GmbH (DE) | 1992-05-06 | — | — | EP | disclosed |
| EP-0342486-A1 | Antibiotic | Dr. Karl Thomae GmbH (DE) | 1989-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428452-B2 | Anti-gram-negative bacterial compound | NIT2, BPGM, FABP2 | SLC7A5 234/4885SLC1A3 1345/4885SLC1A2 464/4885 |
| US-20260116929-A1 | ANTI-GRAM-NEGATIVE BACTERIAL COMPOUND | TLL2, TMPO, BCL2L2 | SLC7A5 838/4885SLC1A3 3034/4885SLC1A2 2122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.